Cancer Patients Benefit from mRNA Vaccines
mRNA vaccines trigger T-cells to attack tumor cells.
1,000 patients analyzed: 884 lung cancer, 180 vaccinated lung cancer, 210 melanoma.
Survival increased from 26.7 to 40 months.
Researchers plan lung cancer clinical trials by year-end.
Study is retrospective, raising concerns about confounding factors.
Funding cut by Robert F. Kennedy Jr. faces skepticism.
2 weeks ago